Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Betaine is a methyl group donor used for the treatment of homocystinuria to decrease elevated homocysteine blood levels. Betaine is a methyl group donor that functions in the normal metabolic cycle of methionine.
- Mechanism
- Curator reviewed · 6 references
Homocystinuria is a hereditary disorder characterized by high levels of the amino acid homocysteine. This condition can be caused by deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl). CBS converts homocysteine to cystathionine, and a deficiency in this enzyme can lead to an accumulation of homocysteine. MTHFR is responsible for producing 5-methyltetrahydrofolate, a methyl donor that participates in the conversion of homocysteine back to methionine; therefore, an MTHFR deficiency can also lead to homocystinuria. Additionally, a defect in cobalamin (vitamin B12) cofactor metabolism can lead to homocystinuria, since a metabolite of cobalamin (methylcobalamin) promotes the conversion of homocysteine to methionine.
Betaine transfers a methyl group via the enzyme betaine homocysteine methyl transferase (BHMT), converting homocysteine back into methionine and dimethylglycine (DMG). In patients with homocystinuria, betaine reduces homocysteine levels and improves health outcomes.
- Primary indication
- Betaine is indicated for the treatment of homocystinuria in pediatric and adult patients to decrease elevated homocysteine blood levels.Curator reviewed · 4 structured indications
- Formula / weight
- C5H11NO2 · 117.1463 g/mol (avg)
- First approval
- Canada, 2018 · United States, 1996 · European Union, 2016
- Also known as
- 2-trimethylammonioacetate · Abromine · Acidol · Glycine betaine · Glycinebetaine
- Code names
- FEMA NO. 4223 · NSC-166511
- Brand names
- Amversio
- Cystadane
- EnBrace HR
- EnLyte
Resolves to
KWIUHFFTVRNATP-UHFFFAOYSA-NSMILESC[N+](C)(C)CC([O-])=OWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Betaine, and which of those have an active Phase 3 trial?